NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1720393136|ref|XP_030106339|]
View 

lung adenoma susceptibility protein 2 isoform X1 [Mus musculus]

Protein Classification

LAS2 domain-containing protein( domain architecture ID 11239280)

LAS2 domain-containing protein

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

 Name Accession Description Interval E-value
LAS2 pfam15792
Lung adenoma susceptibility protein 2; LAS2 is a family of eukaryotic proteins. Deletion of ...
 143-217 1.04e-27

Lung adenoma susceptibility protein 2; LAS2 is a family of eukaryotic proteins. Deletion of LAS2 is observed in approx. 40% of human lung adenocarcinomas, suggesting that loss of function of LAS2 may be a key step for promoting lung tumourigenesis.


:

Pssm-ID: 464872  Cd Length: 75  Bit Score: 104.86  E-value: 1.04e-27
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1720393136 143 SSDIKNSPSFYVDATSKSKNNIVPPYVYTNINGKKCGRPRTPKPINRENKCVSESSLSFPKESSFTEDSAERRLE 217
Cdd:pfam15792   1 SLDIEKNPNFQEPSTPMGKDNLVTPVVYTNINGKQCGRLKNPKLINKANKCLSESSLSFPKKSSFKDSSPCSLEK 75
LAS2 super family cl24379
Lung adenoma susceptibility protein 2; LAS2 is a family of eukaryotic proteins. Deletion of ...
 313-369 1.29e-10

Lung adenoma susceptibility protein 2; LAS2 is a family of eukaryotic proteins. Deletion of LAS2 is observed in approx. 40% of human lung adenocarcinomas, suggesting that loss of function of LAS2 may be a key step for promoting lung tumourigenesis.


The actual alignment was detected with superfamily member pfam15792:

Pssm-ID: 464872  Cd Length: 75  Bit Score: 57.10  E-value: 1.29e-10
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1720393136 313 EFKCQCDN----PLLPGQSQKPFCGD-KIELLILKAKKNLKQSAKDLPKPVE-KDDSPCSLDK 369
Cdd:pfam15792  13 PSTPMGKDnlvtPVVYTNINGKQCGRlKNPKLINKANKCLSESSLSFPKKSSfKDSSPCSLEK 75
 
Name Accession Description Interval E-value
LAS2 pfam15792
Lung adenoma susceptibility protein 2; LAS2 is a family of eukaryotic proteins. Deletion of ...
 143-217 1.04e-27

Lung adenoma susceptibility protein 2; LAS2 is a family of eukaryotic proteins. Deletion of LAS2 is observed in approx. 40% of human lung adenocarcinomas, suggesting that loss of function of LAS2 may be a key step for promoting lung tumourigenesis.


Pssm-ID: 464872  Cd Length: 75  Bit Score: 104.86  E-value: 1.04e-27
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1720393136 143 SSDIKNSPSFYVDATSKSKNNIVPPYVYTNINGKKCGRPRTPKPINRENKCVSESSLSFPKESSFTEDSAERRLE 217
Cdd:pfam15792   1 SLDIEKNPNFQEPSTPMGKDNLVTPVVYTNINGKQCGRLKNPKLINKANKCLSESSLSFPKKSSFKDSSPCSLEK 75
LAS2 pfam15792
Lung adenoma susceptibility protein 2; LAS2 is a family of eukaryotic proteins. Deletion of ...
 313-369 1.29e-10

Lung adenoma susceptibility protein 2; LAS2 is a family of eukaryotic proteins. Deletion of LAS2 is observed in approx. 40% of human lung adenocarcinomas, suggesting that loss of function of LAS2 may be a key step for promoting lung tumourigenesis.


Pssm-ID: 464872  Cd Length: 75  Bit Score: 57.10  E-value: 1.29e-10
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1720393136 313 EFKCQCDN----PLLPGQSQKPFCGD-KIELLILKAKKNLKQSAKDLPKPVE-KDDSPCSLDK 369
Cdd:pfam15792  13 PSTPMGKDnlvtPVVYTNINGKQCGRlKNPKLINKANKCLSESSLSFPKKSSfKDSSPCSLEK 75
 
Name Accession Description Interval E-value
LAS2 pfam15792
Lung adenoma susceptibility protein 2; LAS2 is a family of eukaryotic proteins. Deletion of ...
 143-217 1.04e-27

Lung adenoma susceptibility protein 2; LAS2 is a family of eukaryotic proteins. Deletion of LAS2 is observed in approx. 40% of human lung adenocarcinomas, suggesting that loss of function of LAS2 may be a key step for promoting lung tumourigenesis.


Pssm-ID: 464872  Cd Length: 75  Bit Score: 104.86  E-value: 1.04e-27
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1720393136 143 SSDIKNSPSFYVDATSKSKNNIVPPYVYTNINGKKCGRPRTPKPINRENKCVSESSLSFPKESSFTEDSAERRLE 217
Cdd:pfam15792   1 SLDIEKNPNFQEPSTPMGKDNLVTPVVYTNINGKQCGRLKNPKLINKANKCLSESSLSFPKKSSFKDSSPCSLEK 75
LAS2 pfam15792
Lung adenoma susceptibility protein 2; LAS2 is a family of eukaryotic proteins. Deletion of ...
 313-369 1.29e-10

Lung adenoma susceptibility protein 2; LAS2 is a family of eukaryotic proteins. Deletion of LAS2 is observed in approx. 40% of human lung adenocarcinomas, suggesting that loss of function of LAS2 may be a key step for promoting lung tumourigenesis.


Pssm-ID: 464872  Cd Length: 75  Bit Score: 57.10  E-value: 1.29e-10
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1720393136 313 EFKCQCDN----PLLPGQSQKPFCGD-KIELLILKAKKNLKQSAKDLPKPVE-KDDSPCSLDK 369
Cdd:pfam15792  13 PSTPMGKDnlvtPVVYTNINGKQCGRlKNPKLINKANKCLSESSLSFPKKSSfKDSSPCSLEK 75
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH